Search research articles
Contact Us
Filters
Showing results (191-200 of 218) with videos related to
Page
of 22
Sort By:
Journal of Endocrinological Investigation
|
November 3, 2014
Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA
G Aimaretti, R Attanasio, S Cannavò, et al.
International Journal of Cancer
|
July 4, 2001
Non-Hodgkin lymphoma among young adults with and without AIDS in Italy
L Dal Maso, G Rezza, P Zambon, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
September 1, 2001
Management of puberty in constitutional delay of growth and puberty
F De Luca, J Argente, L Cavallo, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
Diabetologia
|
March 29, 2001
Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus
T Not, A Tommasini, G Tonini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 2013
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1
R Scarpa, R Alaggio, L Norberto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2015
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
C Cremolini, F Loupakis, C Antoniotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
C Cremolini, F Loupakis, G Masi, et al.
Page
of 22
Search research articles
Search
Showing results (191-200 of 218) with videos related to
Sort By:
Page
of 22
Journal of Endocrinological Investigation
|
November 3, 2014
Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP/ISPED, AME, SIE, SIMA
G Aimaretti, R Attanasio, S Cannavò, et al.
International Journal of Cancer
|
July 4, 2001
Non-Hodgkin lymphoma among young adults with and without AIDS in Italy
L Dal Maso, G Rezza, P Zambon, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
September 1, 2001
Management of puberty in constitutional delay of growth and puberty
F De Luca, J Argente, L Cavallo, et al.
British Journal of Cancer
|
August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
F Graziano, A Ruzzo, F Loupakis, et al.
Diabetologia
|
March 29, 2001
Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus
T Not, A Tommasini, G Tonini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 1, 2013
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1
R Scarpa, R Alaggio, L Norberto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2012
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?
D Santini, B Vincenzi, R Addeo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2015
Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest
C Cremolini, F Loupakis, C Antoniotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2016
FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials
C Cremolini, F Loupakis, G Masi, et al.
Page
of 22